Verisign, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Verisign, Inc. trades at $277.5 (market cap $25.26B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Verisign, Inc. is the larger of the two by market cap, and Verisign, Inc. pays the higher dividend (1.17%). Which is the better fit depends on your goals.
| VRSN | ZBH | |
|---|---|---|
Market Cap | $25.26B | $17.36B |
Sector | Technology | Health |
52-Week High | $310.00 | $107.71 |
52-Week Low | $211.49 | $79.58 |
Enterprise Value | $26.50B | $24.40B |
Dividend Yield | 1.17% | 1.07% |
Trailing returns across standard periods
Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →